These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia. Story JY; Zoine JT; Burnham RE; Hamilton JAG; Spencer HT; Doering CB; Raikar SS Cytotherapy; 2021 Jan; 23(1):12-24. PubMed ID: 33168453 [TBL] [Abstract][Full Text] [Related]
6. Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand system. Lazarova M; Wels WS; Steinle A Expert Opin Biol Ther; 2020 Dec; 20(12):1491-1501. PubMed ID: 32726145 [TBL] [Abstract][Full Text] [Related]
7. Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells. Sun B; Yang D; Dai H; Liu X; Jia R; Cui X; Li W; Cai C; Xu J; Zhao X Cancer Immunol Res; 2019 Nov; 7(11):1813-1823. PubMed ID: 31484657 [TBL] [Abstract][Full Text] [Related]
8. A novel approach for relapsed/refractory FLT3 Li KX; Wu HY; Pan WY; Guo MQ; Qiu DZ; He YJ; Li YH; Yang DH; Huang YX Mol Cancer; 2022 Mar; 21(1):66. PubMed ID: 35246156 [TBL] [Abstract][Full Text] [Related]
9. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors. Parihar R; Rivas C; Huynh M; Omer B; Lapteva N; Metelitsa LS; Gottschalk SM; Rooney CM Cancer Immunol Res; 2019 Mar; 7(3):363-375. PubMed ID: 30651290 [TBL] [Abstract][Full Text] [Related]
10. Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy. Murad JM; Baumeister SH; Werner L; Daley H; Trébéden-Negre H; Reder J; Sentman CL; Gilham D; Lehmann F; Snykers S; Sentman ML; Wade T; Schmucker A; Fanger MW; Dranoff G; Ritz J; Nikiforow S Cytotherapy; 2018 Jul; 20(7):952-963. PubMed ID: 30180944 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer. Zhang Y; Liang K; Zhou X; Zhang X; Xu H; Dai H; Song X; Yang X; Liu B; Shi T; Wei J Cancer Sci; 2023 Jul; 114(7):2798-2809. PubMed ID: 37151176 [TBL] [Abstract][Full Text] [Related]
12. T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells. Yang D; Sun B; Dai H; Li W; Shi L; Zhang P; Li S; Zhao X J Immunother Cancer; 2019 Jul; 7(1):171. PubMed ID: 31288857 [TBL] [Abstract][Full Text] [Related]
13. A novel MICA/B-targeted chimeric antigen receptor augments the cytotoxicity of NK cells against tumor cells. Guo C; Dong M; Wang X; Yu J; Jin X; Cheng S; Cui F; Qian Y; Bao Q; Zhi L; Niu Z; Li M; Zhu W Biochem Biophys Res Commun; 2024 May; 710():149918. PubMed ID: 38598902 [TBL] [Abstract][Full Text] [Related]
14. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition. Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity. Satwani P; Bavishi S; Saha A; Zhao F; Ayello J; van de Ven C; Chu Y; Cairo MS Cytotherapy; 2014 Oct; 16(10):1431-40. PubMed ID: 24856896 [TBL] [Abstract][Full Text] [Related]
16. Annihilation of Non-small Cell Lung Cancer by NKG2D CAR-T Cells Produced from T Cells from Peripheral Blood of Healthy Donors. Jiang J; Liu Y; Zeng Y; Fang B; Chen Y J Interferon Cytokine Res; 2023 Oct; 43(10):445-454. PubMed ID: 37819621 [TBL] [Abstract][Full Text] [Related]
17. GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy. Fernández L; Fernández A; Mirones I; Escudero A; Cardoso L; Vela M; Lanzarot D; de Paz R; Leivas A; Gallardo M; Marcos A; Romero AB; Martínez-López J; Pérez-Martínez A Front Immunol; 2019; 10():2361. PubMed ID: 31649672 [TBL] [Abstract][Full Text] [Related]
18. Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia. Wen J; Chen Y; Yang J; Dai C; Yu S; Zhong W; Liu L; He C; Zhang W; Yang T; Liu L; Hu J J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37524506 [TBL] [Abstract][Full Text] [Related]
19. [Construction of NKG2D CAR-NK92 cells and its killing effect on multiple myeloma cells]. Long J; Zheng R; Ye S; Ke S; Duan D; Wei C; Gao J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):577-585. PubMed ID: 37403715 [TBL] [Abstract][Full Text] [Related]